What is the current annual cash from operations of GSK?

As of today, GSK annual cash from operations is $9.62B

What is 1-year change in GSK annual cash from operations?

GSK annual cash from operations is up +23.66% year-over-year

What is 3-year change in GSK annual cash from operations?

GSK annual cash from operations is up +17.94% over the past 3 years

How far is GSK annual cash from operations from its all-time high?

GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on December 31, 2008

How does GSK annual cash from operations rank versus sector peers?

GSK annual cash from operations is higher than 98.67% of companies in Healthcare sector

When is GSK next annual earnings release?

As of today, the next annual earnings release for GSK has not been scheduled

What is the current quarterly cash from operations of GSK?

As of today, GSK quarterly cash from operations is $3.39B

What is GSK quarterly cash from operations most recent change?

GSK quarterly cash from operations was up +128.23% on June 30, 2026

What is 1-year change in GSK quarterly cash from operations?

GSK quarterly cash from operations is up +37.40% year-over-year

How far is GSK quarterly cash from operations from its all-time high?

GSK quarterly cash from operations is currently -33.84% below its historical high of $5.12B set on December 31, 2018

How does GSK quarterly cash from operations rank versus sector peers?

GSK quarterly cash from operations is higher than 98.85% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

What is the current TTM cash from operations of GSK?

As of today, GSK TTM cash from operations is $10.64B

What is GSK TTM cash from operations most recent change?

GSK TTM cash from operations was up +9.48% on June 30, 2026

What is 1-year change in GSK TTM cash from operations?

GSK TTM cash from operations is up +12.71% year-over-year

How far is GSK TTM cash from operations from its all-time high?

GSK TTM cash from operations is currently -18.76% below its historical high of $13.10B set on June 30, 2022

How does GSK TTM cash from operations rank versus sector peers?

GSK TTM cash from operations is higher than 98.76% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

GSK Plc (GSK) CFO History & Chart Since 1991

Annual CFO

$9.62B$1.84B+23.66%

December 31, 2025

Summary

Current Value: As of today, GSK annual cash from operations is $9.62B, up +23.66% on December 31, 2025
Historical Performance: GSK annual cash from operations is up +17.94% over the past 3 years, down -1.85% over the past 5 years
All-Time High Comparison: GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on December 31, 2008
3-Year Low Comparison: GSK annual cash from operations is +23.66% above its 3-year low of $7.78B reached on December 31, 2024
Sector Comparison: GSK annual cash from operations is higher than 98.67% of companies in Healthcare sector

Cash From Operations Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash From Operations	Dec 31, 25	$9.62B	+23.7%	+17.9%	-1.9%	+1.4%
Quarterly Cash From Operations	Jun 30, 26	$3.39B	+37.4%	+152.8%	+151.0%	+103.1%
TTM Cash From Operations	Jun 30, 26	$10.64B	+12.7%	+128.9%	+44.9%	+58.5%
Price	Aug 27, 26	$50.27	+27.5%	+43.2%	+20.8%	+17.6%
Annual Cash From Investing	Dec 31, 25	-$5.90B	-232.2%	+45.8%	-319.6%	-91.7%
Annual Cash From Financing	Dec 31, 25	-$3.96B	+24.4%	-293.4%	+66.7%	+46.5%
Annual Free Cash Flow	Dec 31, 25	$5.69B	+43.2%	+5.8%	-17.9%	-18.3%
Annual CAPEX	Dec 31, 25	$3.93B	+3.2%	+41.4%	+37.0%	+55.9%
Annual Net Income	Dec 31, 25	$8.29B	+119.8%	+36.7%	+1.2%	+189.8%

Cash From Operations Highs

GSK Annual Cash From Operations Highs Comparison
Period	High	Date	Current
3Y	$9.62B	Dec 31, 25	at high
5Y	$9.91B	Dec 31, 21	-2.8%
All	$12.53B	Dec 31, 08	-23.2%

Cash From Operations Lows

GSK Annual Cash From Operations Lows Comparison
Period	Low	Date	Current
3Y	$7.78B	Dec 31, 24	+23.7%
5Y	$7.78B	Dec 31, 24	+23.7%
All	$1.75B	Jun 30, 91	+449.3%

Cash From Operations History

Year	Value	Change
2025	$9.62B	+23.7%
2024	$7.78B	-1.4%
2023	$7.89B	-3.3%
2022	$8.16B	-17.6%
2021	$9.91B	+1.0%
2020	$9.81B	+6.6%
2019	$9.20B	-11.1%
2018	$10.36B	+29.5%
2017	$7.99B	+1.1%
2016	$7.91B	+170.8%
2015	$2.92B	-60.9%
2014	$7.47B	-27.2%
2013	$10.26B	+76.3%
2012	$5.82B	-35.2%
2011	$8.98B	-5.3%
2010	$9.49B	-15.7%
2009	$11.25B	-10.2%
2008	$12.53B	+3.6%

Year	Value	Change
2007	$12.09B	+54.3%
2006	$7.84B	-26.6%
2005	$10.68B	+22.0%
2004	$8.75B	+8.1%
2003	$8.10B	-1.7%
2002	$8.24B	+21.1%
2001	$6.81B	+11.6%
2000	$6.10B	+5.6%
1999	$5.78B	+108.2%
1998	$2.77B	-7.5%
1997	$3.00B	+1.7%
1996	$2.95B	-32.8%
1995	$4.38B	+79.4%
1994	$2.44B	+3.4%
1993	$2.36B	+20.7%
1992	$1.96B	+11.7%
1991	$1.75B	-

FAQ

What is the current annual cash from operations of GSK?: As of today, GSK annual cash from operations is $9.62B
What is 1-year change in GSK annual cash from operations?: GSK annual cash from operations is up +23.66% year-over-year
What is 3-year change in GSK annual cash from operations?: GSK annual cash from operations is up +17.94% over the past 3 years
How far is GSK annual cash from operations from its all-time high?: GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on December 31, 2008
How does GSK annual cash from operations rank versus sector peers?: GSK annual cash from operations is higher than 98.67% of companies in Healthcare sector
When is GSK next annual earnings release?: As of today, the next annual earnings release for GSK has not been scheduled

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

Quarterly CFO

$3.39B$1.90B+128.23%

June 30, 2026

Summary

Current Value: As of today, GSK quarterly cash from operations is $3.39B, up +128.23% on June 30, 2026
Historical Performance: GSK quarterly cash from operations is up +37.40% year-over-year, up +152.80% over the past 3 years
All-Time High Comparison: GSK quarterly cash from operations is currently -33.84% below its historical high of $5.12B set on December 31, 2018
3-Year Low Comparison: GSK quarterly cash from operations is +204.82% above its 3-year low of $1.11B reached on June 30, 2024
Sector Comparison: GSK quarterly cash from operations is higher than 98.85% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash From Operations	Jun 30, 26	$3.39B	+128.2%	+37.4%	+152.8%	+151.0%
Annual Cash From Operations	Dec 31, 25	$9.62B	–	+23.7%	+17.9%	-1.9%
TTM Cash From Operations	Jun 30, 26	$10.64B	+9.5%	+12.7%	+128.9%	+44.9%
Price	Aug 27, 26	$50.27	-1.9%	+27.5%	+43.2%	+20.8%
Quarterly Cash From Investing	Jun 30, 26	-$1.18B	+34.1%	-42.8%	+11.6%	-330.2%
Quarterly Cash From Financing	Jun 30, 26	-$2.54B	-1209.8%	+8.4%	-678.3%	-6.1%
Quarterly Free Cash Flow	Jun 30, 26	$2.51B	+183.3%	+53.9%	+277.1%	+338.0%
Quarterly CAPEX	Jun 30, 26	$874.46M	+46.5%	+5.1%	+29.9%	+12.8%
Quarterly Net Income	Jun 30, 26	$742.26M	-70.0%	-66.2%	-66.0%	-58.2%

Quarterly Cash From Operations Highs

GSK Quarterly Cash From Operations Highs Comparison
Period	High	Date	Current
1Y	$3.39B	Jun 30, 26	at high
3Y	$3.62B	Dec 31, 23	-6.4%
5Y	$4.70B	Dec 31, 21	-28.0%
All	$5.12B	Dec 31, 18	-33.8%

Quarterly Cash From Operations Lows

GSK Quarterly Cash From Operations Lows Comparison
Period	Low	Date	Current
1Y	$1.48B	Mar 31, 26	+128.2%
3Y	$1.11B	Jun 30, 24	+204.8%
5Y	$115.43M	Mar 31, 23	+2833.1%
All	-$2.73B	Dec 31, 00	+224.0%

Quarterly Cash From Operations History

Month	Value	Change
Jun 2026	$3.39B	+128.2%
Mar 2026	$1.48B	-45.9%
Dec 2025	$2.74B	-9.5%
Sep 2025	$3.03B	+23.0%
Jun 2025	$2.46B	+73.3%
Mar 2025	$1.42B	-49.8%
Dec 2024	$2.83B	+4.1%
Sep 2024	$2.72B	+145.2%
Jun 2024	$1.11B	-6.7%
Mar 2024	$1.19B	-67.1%
Dec 2023	$3.62B	+30.2%
Sep 2023	$2.78B	+107.6%
Jun 2023	$1.34B	+1,060.3%
Mar 2023	$115.43M	-93.4%
Dec 2022	$1.75B	+21.0%
Sep 2022	$1.45B	-8.7%
Jun 2022	$1.58B	-52.1%
Mar 2022	$3.31B	-29.6%
Dec 2021	$4.70B	+34.2%
Sep 2021	$3.50B	+159.8%
Jun 2021	$1.35B	+300.9%
Mar 2021	$336.45M	-92.7%
Dec 2020	$4.63B	+347.5%
Sep 2020	$1.03B	-65.4%
Jun 2020	$2.99B	+159.5%
Mar 2020	$1.15B	-70.3%
Dec 2019	$3.87B	+24.5%
Sep 2019	$3.11B	+122.7%
Jun 2019	$1.40B	+88.4%
Mar 2019	$741.04M	-85.5%
Dec 2018	$5.12B	+95.1%
Sep 2018	$2.62B	+70.4%
Jun 2018	$1.54B	+34.6%
Mar 2018	$1.14B	-64.9%
Dec 2017	$3.26B	+33.8%
Sep 2017	$2.44B	+159.3%
Jun 2017	$940.07M	-29.4%
Mar 2017	$1.33B	-61.8%
Dec 2016	$3.48B	+47.7%
Sep 2016	$2.36B	+62.9%
Jun 2016	$1.45B	+135.0%
Mar 2016	$616.16M	-66.7%
Dec 2015	$1.85B	+187.6%
Sep 2015	$644.02M	+1,327.2%
Jun 2015	-$52.48M	-110.8%
Mar 2015	$487.92M	-84.6%
Dec 2014	$3.16B	+57.1%
Sep 2014	$2.01B	+118.5%
Jun 2014	$919.98M	-35.2%
Mar 2014	$1.42B	-55.2%
Dec 2013	$3.17B	+4.2%
Sep 2013	$3.04B	+39.7%
Jun 2013	$2.18B	+15.9%

Month	Value	Change
Mar 2013	$1.88B	-25.1%
Dec 2012	$2.51B	+563.4%
Sep 2012	-$540.76M	-122.9%
Jun 2012	$2.37B	+58.5%
Mar 2012	$1.49B	-48.4%
Dec 2011	$2.89B	-1.4%
Sep 2011	$2.93B	+75.8%
Jun 2011	$1.67B	+8.7%
Mar 2011	$1.53B	-15.8%
Dec 2010	$1.82B	+7.5%
Sep 2010	$1.69B	-37.7%
Jun 2010	$2.72B	-16.4%
Mar 2010	$3.25B	+7.8%
Dec 2009	$3.02B	-12.2%
Sep 2009	$3.44B	+48.0%
Jun 2009	$2.32B	-6.0%
Mar 2009	$2.47B	-10.7%
Dec 2008	$2.77B	-24.4%
Sep 2008	$3.66B	+50.7%
Jun 2008	$2.43B	-33.9%
Mar 2008	$3.67B	+32.8%
Dec 2007	$2.77B	-24.3%
Sep 2007	$3.65B	+39.8%
Jun 2007	$2.61B	-15.9%
Mar 2007	$3.11B	+17.2%
Dec 2006	$2.65B	>+9,900.0%
Sep 2006	$50.10K	-100.0%
Jun 2006	$2.04B	-34.2%
Mar 2006	$3.09B	+35.4%
Dec 2005	$2.29B	-29.8%
Sep 2005	$3.26B	+16.7%
Jun 2005	$2.79B	+17.2%
Mar 2005	$2.38B	+48.6%
Dec 2004	$1.60B	-43.5%
Sep 2004	$2.84B	+21.5%
Jun 2004	$2.33B	+23.7%
Mar 2004	$1.89B	+12.4%
Dec 2003	$1.68B	-43.7%
Sep 2003	$2.98B	+82.8%
Jun 2003	$1.63B	-5.2%
Mar 2003	$1.72B	-5.2%
Dec 2002	$1.81B	-27.1%
Sep 2002	$2.49B	+6.3%
Jun 2002	$2.34B	+44.9%
Mar 2002	$1.62B	-25.2%
Dec 2001	$2.16B	+20.2%
Sep 2001	$1.80B	-9.0%
Jun 2001	$1.97B	+130.3%
Mar 2001	$857.53M	+131.4%
Dec 2000	-$2.73B	-179.8%
Sep 2000	$3.42B	+1,599.9%
Jun 2000	$201.19M	-89.5%
Mar 2000	$1.92B	-

FAQ

What is the current quarterly cash from operations of GSK?: As of today, GSK quarterly cash from operations is $3.39B
What is GSK quarterly cash from operations most recent change?: GSK quarterly cash from operations was up +128.23% on June 30, 2026
What is 1-year change in GSK quarterly cash from operations?: GSK quarterly cash from operations is up +37.40% year-over-year
How far is GSK quarterly cash from operations from its all-time high?: GSK quarterly cash from operations is currently -33.84% below its historical high of $5.12B set on December 31, 2018
How does GSK quarterly cash from operations rank versus sector peers?: GSK quarterly cash from operations is higher than 98.85% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TTM CFO

$10.64B$921.57M+9.48%

June 30, 2026

Summary

Current Value: As of today, GSK TTM cash from operations is $10.64B, up +9.48% on June 30, 2026
Historical Performance: GSK TTM cash from operations is up +12.71% year-over-year, up +128.87% over the past 3 years
All-Time High Comparison: GSK TTM cash from operations is currently -18.76% below its historical high of $13.10B set on June 30, 2022
3-Year Low Comparison: GSK TTM cash from operations is +128.87% above its 3-year low of $4.65B reached on an earlier date
Sector Comparison: GSK TTM cash from operations is higher than 98.76% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Cash From Operations	Jun 30, 26	$10.64B	+9.5%	+12.7%	+128.9%	+44.9%
Annual Cash From Operations	Dec 31, 25	$9.62B	–	+23.7%	+17.9%	-1.9%
Quarterly Cash From Operations	Jun 30, 26	$3.39B	+128.2%	+37.4%	+152.8%	+151.0%
Price	Aug 27, 26	$50.27	-1.9%	+27.5%	+43.2%	+20.8%
TTM Cash From Investing	Jun 30, 26	-$8.30B	-4.4%	-70.5%	-12.0%	-653.8%
TTM Cash From Financing	Jun 30, 26	-$2.93B	+7.4%	+25.2%	-2.1%	+75.6%
TTM Free Cash Flow	Jun 30, 26	$6.62B	+15.3%	+21.0%	+246.3%	+59.5%
TTM CAPEX	Jun 30, 26	$4.02B	+1.1%	+1.3%	+46.9%	+26.0%
TTM Net Income	Jun 30, 26	$7.08B	-17.1%	+37.3%	+1.3%	+9.4%

TTM Cash From Operations Highs

GSK TTM Cash From Operations Highs Comparison
Period	High	Date	Current
1Y	$10.64B	Jun 30, 26	at high
3Y	$10.64B	Jun 30, 26	at high
5Y	$13.10B	Jun 30, 22	-18.8%
All	$13.10B	Jun 30, 22	-18.8%

TTM Cash From Operations Lows

GSK TTM Cash From Operations Lows Comparison
Period	Low	Date	Current
1Y	$9.44B	N/A	+12.7%
3Y	$4.65B	N/A	+128.9%
5Y	$4.65B	Jun 30, 23	+128.9%
All	$1.75B	Mar 31, 01	+508.5%

TTM Cash From Operations History

Month	Value	Change
Jun 2026	$10.64B	+9.5%
Mar 2026	$9.72B	+0.6%
Dec 2025	$9.66B	-0.9%
Sep 2025	$9.75B	+3.3%
Jun 2025	$9.44B	+16.7%
Mar 2025	$8.09B	+2.9%
Dec 2024	$7.86B	-9.1%
Sep 2024	$8.64B	-0.6%
Jun 2024	$8.70B	-2.6%
Mar 2024	$8.93B	+13.7%
Dec 2023	$7.85B	+31.2%
Sep 2023	$5.98B	+28.7%
Jun 2023	$4.65B	-5.0%
Mar 2023	$4.90B	-39.5%
Dec 2022	$8.09B	-26.7%
Sep 2022	$11.04B	-15.7%
Jun 2022	$13.10B	+1.8%
Mar 2022	$12.87B	+30.1%
Dec 2021	$9.89B	+0.8%
Sep 2021	$9.82B	+33.6%
Jun 2021	$7.35B	-18.2%
Mar 2021	$8.98B	-8.3%
Dec 2020	$9.80B	+8.3%
Sep 2020	$9.04B	-18.7%
Jun 2020	$11.12B	+16.7%
Mar 2020	$9.53B	+4.5%
Dec 2019	$9.12B	-12.0%
Sep 2019	$10.36B	+4.9%
Jun 2019	$9.88B	-1.4%
Mar 2019	$10.02B	-3.9%
Dec 2018	$10.42B	+21.7%
Sep 2018	$8.57B	+2.2%
Jun 2018	$8.38B	+7.7%
Mar 2018	$7.78B	-2.4%
Dec 2017	$7.97B	-2.7%
Sep 2017	$8.19B	+1.0%
Jun 2017	$8.11B	-5.9%
Mar 2017	$8.62B	+9.1%
Dec 2016	$7.91B	+26.0%
Sep 2016	$6.28B	+37.6%
Jun 2016	$4.56B	+49.0%
Mar 2016	$3.06B	+4.4%
Dec 2015	$2.93B	-30.8%
Sep 2015	$4.24B	-24.4%
Jun 2015	$5.60B	-14.8%
Mar 2015	$6.58B	-12.4%
Dec 2014	$7.51B	-0.1%
Sep 2014	$7.52B	-12.0%
Jun 2014	$8.55B	-12.8%
Mar 2014	$9.80B	-4.5%
Dec 2013	$10.26B	+6.9%
Sep 2013	$9.60B	+59.5%
Jun 2013	$6.02B	-3.1%

Month	Value	Change
Mar 2013	$6.21B	+6.6%
Dec 2012	$5.82B	-6.2%
Sep 2012	$6.21B	-35.9%
Jun 2012	$9.68B	+7.8%
Mar 2012	$8.98B	-0.5%
Dec 2011	$9.02B	+13.4%
Sep 2011	$7.95B	+18.4%
Jun 2011	$6.72B	-13.5%
Mar 2011	$7.77B	-18.1%
Dec 2010	$9.49B	-11.2%
Sep 2010	$10.69B	-14.0%
Jun 2010	$12.43B	+3.3%
Mar 2010	$12.03B	+7.0%
Dec 2009	$11.25B	+2.3%
Sep 2009	$11.00B	-2.0%
Jun 2009	$11.22B	-0.9%
Mar 2009	$11.33B	-9.6%
Dec 2008	$12.53B	-0.0%
Sep 2008	$12.53B	+0.1%
Jun 2008	$12.52B	-1.4%
Mar 2008	$12.71B	+4.7%
Dec 2007	$12.14B	+1.0%
Sep 2007	$12.02B	+43.6%
Jun 2007	$8.37B	+7.4%
Mar 2007	$7.79B	+0.1%
Dec 2006	$7.78B	+4.9%
Sep 2006	$7.42B	-30.5%
Jun 2006	$10.67B	-6.6%
Mar 2006	$11.43B	+6.7%
Dec 2005	$10.71B	+6.8%
Sep 2005	$10.03B	+4.4%
Jun 2005	$9.61B	+5.0%
Mar 2005	$9.15B	+5.7%
Dec 2004	$8.66B	-0.9%
Sep 2004	$8.74B	-1.7%
Jun 2004	$8.89B	+8.6%
Mar 2004	$8.18B	+2.1%
Dec 2003	$8.02B	-1.7%
Sep 2003	$8.15B	+6.5%
Jun 2003	$7.66B	-8.5%
Mar 2003	$8.37B	+1.3%
Dec 2002	$8.26B	-4.0%
Sep 2002	$8.61B	+8.7%
Jun 2002	$7.92B	+4.9%
Mar 2002	$7.55B	+11.2%
Dec 2001	$6.79B	+257.4%
Sep 2001	$1.90B	-46.1%
Jun 2001	$3.52B	+101.4%
Mar 2001	$1.75B	-37.7%
Dec 2000	$2.81B	-49.3%
Sep 2000	$5.54B	+161.6%
Jun 2000	$2.12B	+10.5%
Mar 2000	$1.92B	-

FAQ

What is the current TTM cash from operations of GSK?: As of today, GSK TTM cash from operations is $10.64B
What is GSK TTM cash from operations most recent change?: GSK TTM cash from operations was up +9.48% on June 30, 2026
What is 1-year change in GSK TTM cash from operations?: GSK TTM cash from operations is up +12.71% year-over-year
How far is GSK TTM cash from operations from its all-time high?: GSK TTM cash from operations is currently -18.76% below its historical high of $13.10B set on June 30, 2022
How does GSK TTM cash from operations rank versus sector peers?: GSK TTM cash from operations is higher than 98.76% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk